As shown in Table S3 (Supporting Information), patients with higher levels of MGMT had significantly poorer outcomes, with a hazard ratio (HR) of 1.88, after adjusting for age, sex, tumor size, tumor location, and T/N/M stage. Here, MGMT is linked to neoplasm.